FDA OKs first-of-its-kind T-cell cancer therapy developed by Penn & CHOP By: Philadelphia Business Journal via Business Journals August 30, 2017 at 13:59 PM EDT The therapy treats cancer by boosting the ability of a patient's own immune systems to identify and kill tumors. Read More >>
